RestructuringMay 15, 2026, 04:13 PM
BioAtla Warns on Going Concern, Cuts 70% Workforce; Q1 Net Loss $(6.34)M
AI Summary
BioAtla, Inc. reported a net loss of $(6.34) million for Q1 2026, a significant improvement from $(15.33) million in Q1 2025, driven by reduced operating expenses. However, the company issued a going concern warning, citing cumulative operating losses and negative cash flows. In response, BioAtla initiated a formal process to explore strategic options and implemented a 70% workforce reduction.
Key Highlights
- Management concluded substantial doubt about BioAtla's ability to continue as a going concern.
- Implemented a restructuring plan including a 70% workforce reduction in March 2026.
- Reported Q1 2026 net loss of $(6.34) million, significantly improved from $(15.33) million in Q1 2025.
- Net loss per common share was $(4.22) in Q1 2026, compared to $(13.16) in Q1 2025.
- Total operating expenses decreased to $9.31 million in Q1 2026 from $17.61 million in Q1 2025.
- Cash and cash equivalents stood at $1.96 million as of March 31, 2026.
- Net cash used in operating activities improved to $(5.27) million in Q1 2026.
- Stockholders approved a 1-for-50 reverse stock split (Share Consolidation) effective April 6, 2026.
Price Impact
More from BCAB